[{'title': 'Sanofi Forges Second Partnership to Develop COVID-19 Vaccine ', 'link': 'https://www.biospace.com/article/sanofi-translate-bio-pair-up-to-develop-mrna-vaccine-for-covid-19/'}, {'title': 'Biopharma Industry News for March 27: Update on the Novel Coronavirus', 'link': 'https://www.biospace.com/article/biopharma-industry-news-for-march-27-update-on-the-novel-coronavirus/'}, {'title': 'BMS, Merck and Pfizer Join List of Companies Pausing Some Clinical Trials During Pandemic', 'link': 'https://www.biospace.com/article/merck-bms-pfizer-and-others-pause-enrollment-in-some-clinical-trials-due-to-covid-19/'}, {'title': 'BioSpace Movers & Shakers, March 27', 'link': 'https://www.biospace.com/article/biospace-movers-and-shakers-march-27/'}, {'title': ' Research Roundup: Social Distancing Works and More', 'link': 'https://www.biospace.com/article/-research-roundup-social-distancing-works-and-more/'}, {'title': 'Biotech Calls for More Collaboration and Communication During COVID-19 Pandemic', 'link': 'https://www.biospace.com/article/biotech-calls-for-more-collaboration-and-communication-during-covid-19-pandemic/'}, {'title': 'With Pivots and Clinical Holds, Troubled Unum Considering its Strategic Options', 'link': 'https://www.biospace.com/article/unum-evaluating-strategic-options-including-sale-or-merger/'}, {'title': 'Genentech’s Xofluza Submitted to FDA for New Children’s Formulations', 'link': 'https://www.biospace.com/article/genentech-s-xofluza-submitted-to-fda-for-new-children-s-formulations/'}, {'title': 'CG Oncology Announces License and Commercialization Agreement with Kissei Pharmaceutical Co., Ltd. for CG0070 in Japan and Other Asian Countries', 'link': 'https://www.biospace.com/article/releases/cg-oncology-announces-license-and-commercialization-agreement-with-kissei-pharmaceutical-co-ltd-for-cg0070-in-japan-and-other-asian-countries/'}, {'title': 'Luye Pharma Continues to Deliver Strong Growth in 2019', 'link': 'https://www.biospace.com/article/releases/luye-pharma-continues-to-deliver-strong-growth-in-2019/'}, {'title': 'GenScript ProBio Congratulates XlifeSciences on the Start of TAEST16001 Early Phase Clinical Trial', 'link': 'https://www.biospace.com/article/releases/genscript-probio-congratulates-xlifesciences-on-the-start-of-taest16001-early-phase-clinical-trial/'}, {'title': 'TELA Bio Announces Fourth Quarter and Full Year 2019 Financial Results', 'link': 'https://www.biospace.com/article/releases/tela-bio-announces-fourth-quarter-and-full-year-2019-financial-results/'}, {'title': 'Altimmune Announces Financial Results for the Year Ended December 31, 2019 and Provides a Corporate UpdateConference Call & Webcast Scheduled for Friday, March 27, at 8:30 am Eastern Time', 'link': 'https://www.biospace.com/article/releases/altimmune-announces-financial-results-for-the-year-ended-december-31-2019-and-provides-a-corporate-updateconference-call-and-webcast-scheduled-for-friday-march-27-at-8-30-am-eastern-time/'}, {'title': 'Eton Pharmaceuticals Announces Acquisition of U.S Marketing Rights to Pediatric Orphan Drug Alkindi® Sprinkle', 'link': 'https://www.biospace.com/article/releases/eton-pharmaceuticals-announces-acquisition-of-u-s-marketing-rights-to-pediatric-orphan-drug-alkindi-sprinkle/'}, {'title': 'Arcturus COVID-19 Vaccine to Benefit from Duke-NUS Genetic Correlation SystemData will help Arcturus learn more quickly about LUNAR-COV19 efficacy and safety profile', 'link': 'https://www.biospace.com/article/releases/arcturus-covid-19-vaccine-to-benefit-from-duke-nus-genetic-correlation-systemdata-will-help-arcturus-learn-more-quickly-about-lunar-cov19-efficacy-and-safety-profile/'}, {'title': 'Alphamab Oncology Announces Clinical Supply Collaboration with Pfizer on KN026 in Combination with Ibrance(R) (palbociclib)', 'link': 'https://www.biospace.com/article/releases/alphamab-oncology-announces-clinical-supply-collaboration-with-pfizer-on-kn026-in-combination-with-ibrance-r-palbociclib-/'}, {'title': 'Seneca Biopharma, Inc. Reports Year End 2019 Fiscal Results', 'link': 'https://www.biospace.com/article/releases/seneca-biopharma-inc-reports-year-end-2019-fiscal-results/'}, {'title': 'Vycor Medical Reports Financial Results for the year ended December 31st, 2019', 'link': 'https://www.biospace.com/article/releases/vycor-medical-reports-financial-results-for-the-year-ended-december-31st-2019/'}, {'title': 'Cognition Therapeutics Announces Change in Leadership  ', 'link': 'https://www.biospace.com/article/releases/cognition-therapeutics-announces-change-in-leadership-/'}, {'title': 'Aravive Reports Fourth Quarter and Twelve Months Ended December 31, 2019 Financial Results and Provides Recent Corporate Updates', 'link': 'https://www.biospace.com/article/releases/aravive-reports-fourth-quarter-and-twelve-months-ended-december-31-2019-financial-results-and-provides-recent-corporate-updates/'}]